Fasseli Coulibaly's research focuses on understanding and utilizing the architecture of viruses for innovative medical solutions. His work includes pioneering studies of crystallized insect virus proteins which may contribute to developing vaccines for complex diseases such as HIV. By using robust protein microcrystals derived from insect viruses, Coulibaly aims to create a novel platform for viral vaccine delivery, enhanced by the stability of these microcrystals that makes them suitable for use in areas lacking refrigeration. This research is backed by the Bill and Melinda Gates Foundation in collaboration with Burnet Institute. Previously, at the University of Auckland, he achieved a breakthrough in identifying the structure of insect virus proteins using X-ray crystallography, a technique critical for further investigations into viruses like smallpox and hepatitis C. His work has far-reaching implications for antiviral drug development and vaccine design.
Monash Biomedicine Discovery Institute • Clayton, VIC, Australia
Leading research in structural virology, focusing on viral architectures and their implications for drug and vaccine development.